Answers are grounded in this paper and cite their sources.
Background/Objectives: Pulmonary iodine maps are routinely available from photon-counting detector computed tomography (PCD-CT), including examinations not optimized for pulmonary embolism (PE) assessment. We evaluated the frequency and contrast-phase distribution of pulmonary iodine map defects in routine clinical practice. Methods: This retrospective single-center study included 442 contrast-enhanced PCD-CT examinations in 433 patients during March–April 2026, each with whole-lung coverage in at least one postcontrast phase. Examinations were classified as dedicated pulmonary arterial, other whole-lung arterial, or nonarterial-only imaging. Two radiologists independently reviewed iodine maps followed by 70-keV virtual monoenergetic images, with disagreements resolved by consensus. Analyses were descriptive; no independent reference standard was available. Results: Iodine map defects were identified in 4/442 examinations (0.9%; 95% confidence interval, 0.2–2.3%), all corresponding to pulmonary arterial filling defects interpreted as PE. Defects occurred in 2/15 dedicated pulmonary arterial examinations and 2/70 other arterial examinations, versus 0/357 nonarterial-only examinations. In all three iodine-defect-positive examinations with paired later-phase imaging, iodine defects were no longer visible. Overall, PE was identified in 6/442 examinations (1.4%), including three findings absent from the original reports. Interobserver agreement was κ = 0.86 for iodine defects and κ = 0.83 for PE. Conclusions: Arterial-phase iodine maps may provide clues to PE on routine PCD-CT, even when acquisition is not timed to the pulmonary arterial phase. Absence of iodine defects on nonarterial images should not be used to exclude PE. Larger studies are needed to establish diagnostic benefit.
No takes yet. Share an insight, caveat, or question.
Wakui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: